[{"address1": "201 Brookline Avenue", "address2": "Suite 901", "city": "Boston", "state": "MA", "zip": "02215", "country": "United States", "phone": "857 320 4900", "website": "https://www.tangotx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine -cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors, including TNG462, which is in Phase 1/2 clinical trial for treating pancreatic and lung cancer; and TNG456, a brain-penetrant PRMT5 inhibitor for the treatment of glioblastoma. It is developing TNG260, a co-repressor of repressor element-1 silencing transcription inhibitor to reverse the immune evasion effect of serine-threonine kinase 11 loss-of-function mutations for treating lung cancer. The company was founded in 2017 and is headquartered in Boston, Massachusetts.", "fullTimeEmployees": 155, "companyOfficers": [{"maxAge": 1, "name": "Dr. Barbara L. Weber M.D.", "age": 67, "title": "President, CEO & Director", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 1125489, "exercisedValue": 0, "unexercisedValue": 657452}, {"maxAge": 1, "name": "Ms. Daniella  Beckman CPA", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 717616, "exercisedValue": 0, "unexercisedValue": 337565}, {"maxAge": 1, "name": "Mr. Douglas J. Barry Esq., J.D.", "age": 54, "title": "Chief Legal Officer, Chief Compliance Officer & Corporate Secretary", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 674222, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Adam S. Crystal M.D., Ph.D.", "age": 47, "title": "President of Research & Development", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 882167, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Alan  Ashworth FRS, Ph.D.", "age": 63, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1961, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William G. Kaelin Jr., M.D.", "age": 66, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1958, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Antoni  Ribas M.D., Ph.D.", "age": 57, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael  Palmieri Ph.D.", "title": "Chief Technical Operations Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jannik N. Andersen Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Elizabeth Pingpank Hickin", "title": "VP of IR & Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 4, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.69, "open": 7.77, "dayLow": 7.75, "dayHigh": 7.93, "regularMarketPreviousClose": 7.69, "regularMarketOpen": 7.77, "regularMarketDayLow": 7.75, "regularMarketDayHigh": 7.93, "payoutRatio": 0.0, "beta": 1.679, "forwardPE": -5.464789, "volume": 1103142, "regularMarketVolume": 1103142, "averageVolume": 1982892, "averageVolume10days": 2249590, "averageDailyVolume10Day": 2249590, "bid": 5.65, "ask": 9.95, "bidSize": 2, "askSize": 2, "marketCap": 863379520, "fiftyTwoWeekLow": 1.03, "fiftyTwoWeekHigh": 8.8, "allTimeHigh": 18.84, "allTimeLow": 1.03, "priceToSalesTrailing12Months": 35.53587, "fiftyDayAverage": 7.0298, "twoHundredDayAverage": 3.952825, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 717602496, "profitMargins": 0.0, "floatShares": 32384520, "sharesOutstanding": 111260247, "sharesShort": 26798166, "sharesShortPriorMonth": 25156715, "sharesShortPreviousMonthDate": 1755216000, "dateShortInterest": 1757894400, "sharesPercentSharesOut": 0.2409, "heldPercentInsiders": 0.05982, "heldPercentInstitutions": 1.1092501, "shortRatio": 17.76, "shortPercentOfFloat": 0.289, "impliedSharesOutstanding": 111260247, "bookValue": 1.217, "priceToBook": 6.3763356, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -145566000, "trailingEps": -1.32, "forwardEps": -1.42, "enterpriseToRevenue": 29.536, "enterpriseToEbitda": -4.636, "52WeekChange": 0.11015737, "SandP52WeekChange": 0.17904854, "quoteType": "EQUITY", "currentPrice": 7.76, "targetHighPrice": 13.0, "targetLowPrice": 8.0, "targetMeanPrice": 10.875, "targetMedianPrice": 10.5, "recommendationKey": "none", "numberOfAnalystOpinions": 8, "totalCash": 180784992, "totalCashPerShare": 1.625, "ebitda": -154796000, "totalDebt": 35008000, "quickRatio": 4.517, "currentRatio": 4.75, "totalRevenue": 24296000, "debtToEquity": 25.941, "revenuePerShare": 0.221, "returnOnAssets": -0.31744, "returnOnEquity": -0.76088, "grossProfits": -112152000, "freeCashflow": -75292128, "operatingCashflow": -148252992, "revenueGrowth": -0.84, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -12.87865, "financialCurrency": "USD", "symbol": "TNGX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NGM", "messageBoardId": "finmb_424111353", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Tango Therapeutics, Inc.", "longName": "Tango Therapeutics, Inc.", "marketState": "CLOSED", "fiftyTwoWeekChangePercent": 11.015738, "earningsTimestamp": 1754397000, "earningsTimestampStart": 1762345800, "earningsTimestampEnd": 1762345800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.32, "epsForward": -1.42, "epsCurrentYear": -1.08588, "priceEpsCurrentYear": -7.1462774, "fiftyDayAverageChange": 0.7302003, "fiftyDayAverageChangePercent": 0.10387213, "twoHundredDayAverageChange": 3.8071752, "twoHundredDayAverageChangePercent": 0.96315295, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "regularMarketChangePercent": 0.910275, "regularMarketPrice": 7.76, "corporateActions": [], "postMarketTime": 1759522204, "regularMarketTime": 1759521600, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1599139800000, "postMarketChangePercent": 0.0, "postMarketPrice": 7.76, "postMarketChange": 0.0, "regularMarketChange": 0.0700002, "regularMarketDayRange": "7.75 - 7.93", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1982892, "fiftyTwoWeekLowChange": 6.7300005, "fiftyTwoWeekLowChangePercent": 6.5339813, "fiftyTwoWeekRange": "1.03 - 8.8", "fiftyTwoWeekHighChange": -1.04, "fiftyTwoWeekHighChangePercent": -0.11818181, "displayName": "Tango Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-10-04"}]